동물 줄기세포 치료 시장 : 유형별, 종별, 최종사용자별 - 세계 기회 분석 및 산업 예측(2024-2033년)

Animal Stem Cell Therapy Market By Type (Allogenic, Autologous) , By Species (Dog, Cat, Horse) By End User (Veterinary Hospitals, Research Organizations) : Global Opportunity Analysis and Industry Forecast, 2024-2033

US $ 4,425 ￦ 6,232,000

PDF (Business License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 2명 이상이 이용할 경우, 추가 요금을 지불하여 라이선스 업그레이드로 최대 5명까지 이용 가능합니다.

US $ 7,412 ￦ 10,439,000

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

PDF 보고서 및 Excel 데이터를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 보고서 업데이트 서비스가 무료로 제공됩니다.

한글목차

동물 줄기세포 치료 시장

동물 줄기세포 치료 시장은 2023년 2억 5,600만 달러로 평가되며, 2024-2033년 연평균 5.6% 성장하여 2033년에는 4억 4,000만 달러에 달할 것으로 예상됩니다.

동물 줄기세포 치료는 줄기세포를 이용해 동물의 부상을 치료하거나 질병을 치료하는 치료법입니다. 줄기세포는 생체 내 미분화 세포로 다양한 기능을 가진 새로운 세포를 생성할 수 있는 능력을 가지고 있습니다. 줄기세포의 이러한 능력은 손상된 조직과 장기를 복구하는 데 필수적입니다. 줄기세포는 골수, 제대혈, 지방조직 등 신체의 다양한 부위에서 채취할 수 있습니다. 이 치료법은 골관절염, 신경 질환, 힘줄 및 인대 손상, 다양한 자가면역 질환 등 다양한 증상의 치료에 효과가 있는 것으로 입증되었습니다.

전 세계적으로 반려동물을 기르는 인구가 증가하고 반려동물의 라이프스타일과 건강에 대한 지출이 급증하면서 동물 줄기세포 치료 시장의 주요 촉진요인으로 작용하고 있습니다. 또한, 만성 질환 및 건강 관련 질환의 유병률이 동물들 사이에서 증가하고 있으며, 이는 줄기세포 치료에 대한 수요를 증가시키고 있습니다. 기술의 발전과 함께 줄기세포 치료에 AI를 도입하는 추세가 눈에 띄게 증가하고 있으며, AI는 정확도를 높이고 치료 중 합병증에 대처할 수 있는 전례 없는 도구로 입증되고 있습니다. 이 도구는 줄기세포 집락 분류, 세포 형태 식별, 암 줄기세포의 미기록 형태학적 특징 특성화, 약물 효과 예측 등 다양한 절차에 대한 신뢰할 수 있는 프레임워크를 설계하는 데 도움이 될 수 있습니다.

그러나 동물 줄기세포 치료에는 많은 비용이 소요되기 때문에 예산이 한정된 반려동물 보호자들은 이러한 치료를 받을 수 없는 실정입니다. 또한 줄기세포의 유용성에 대한 윤리적 고려가 시장 개척에 걸림돌로 작용하고 있습니다. 예를 들어, 유럽의약품청(European Medicines Agency)은 동물용 줄기세포 치료제에 대한 엄격한 평가 프로세스를 도입하고 있습니다.

부문별 리뷰

동물 줄기세포 치료 시장은 유형, 종, 최종사용자, 지역으로 구분됩니다. 유형별로는 동종 줄기세포 치료와 자가 줄기세포 치료로 나뉩니다. 종별로는 개, 고양이, 말 등으로 나뉩니다. 최종사용자별로는 동물병원과 연구기관으로 분류됩니다. 지역별로는 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카로 분석됩니다.

주요 조사 결과

유형별로는 동종계열이 2023년 가장 높은 시장 점유율을 차지했습니다.

최종사용자별로는 개 부문이 2023년 시장에서 높은 점유율을 차지했습니다.

지역별로는 북미가 2023년 가장 높은 수익을 올렸습니다.

본 보고서에서 가능한 커스터마이징(추가 비용 및 일정이 있습니다.)

• 고객의 관심사에 따른 기업 프로파일 추가

목차

제1장 소개

제2장 주요 요약

제3장 시장 상황

• 시장 정의와 범위
• 주요 조사 결과
  • 주요 투자 기회
  • 주요 성공 전략
• Porter's Five Forces 분석
• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회

제4장 동물 줄기세포 치료 : 기회 분석과 산업 예측, 2024-2033년 시장, 유형별

• 시장 개요
• 동종이계
• 자가유래

제5장 동물 줄기세포 치료 : 기회 분석과 산업 예측, 2024-2033년 시장, 종별

• 시장 개요
• 개
• 고양이
• 말

제6장 동물 줄기세포 치료 : 기회 분석과 산업 예측, 2024-2033년 시장, 최종사용자별

• 시장 개요
• 동물 병원
• 연구기관

제7장 동물 줄기세포 치료 : 기회 분석과 산업 예측, 2024-2033년 시장, 지역별

• 시장 개요
• 북미
  • 주요 시장 동향과 기회
  • 미국의 동물 줄기세포 치료 : 기회 분석과 산업 예측, 2024-2033년 시장
  • 캐나다의 동물 줄기세포 치료 : 기회 분석과 산업 예측, 2024-2033년 시장
  • 멕시코의 동물 줄기세포 치료 : 기회 분석과 산업 예측, 2024-2033년 시장
• 유럽
  • 주요 시장 동향과 기회
  • 프랑스의 동물 줄기세포 치료 : 기회 분석과 산업 예측, 2024-2033년 시장
  • 독일의 동물 줄기세포 치료 : 기회 분석과 산업 예측, 2024-2033년 시장
  • 이탈리아의 동물 줄기세포 치료 : 기회 분석과 산업 예측, 2024-2033년 시장
  • 스페인의 동물 줄기세포 치료 : 기회 분석과 산업 예측, 2024-2033년 시장
  • 영국의 동물 줄기세포 치료 : 기회 분석과 산업 예측, 2024-2033년 시장
  • 기타 유럽의 동물 줄기세포 치료 : 기회 분석과 산업 예측, 2024-2033년 시장
• 아시아태평양
  • 주요 시장 동향과 기회
  • 중국의 동물 줄기세포 치료 : 사업 기회 분석과 산업 예측, 2024-2033년 시장
  • 일본의 동물 줄기세포 치료 : 기회 분석과 산업 예측, 2024-2033년 시장
  • 인도의 동물 줄기세포 치료 : 기회 분석과 산업 예측, 2024-2033년 시장
  • 한국의 동물 줄기세포 치료 : 기회 분석과 산업 예측, 2024-2033년 시장
  • 호주의 동물 줄기세포 치료 : 기회 분석과 산업 예측, 2024-2033년 시장
  • 기타 아시아태평양의 동물 줄기세포 치료 : 기회 분석과 산업 예측, 2024-2033년 시장
• 라틴아메리카, 중동 및 아프리카
  • 주요 시장 동향과 기회
  • 브라질의 동물 줄기세포 치료 : 기회 분석과 산업 예측, 2024-2033년 시장
  • 남아프리카공화국의 동물 줄기세포 치료 : 기회 분석과 산업 예측, 2024-2033년 시장
  • 사우디아라비아의 동물 줄기세포 치료 : 기회 분석과 산업 예측, 2024-2033년 시장
  • 기타 라틴아메리카, 중동 및 아프리카의 동물 줄기세포 치료 : 기회 분석과 산업 예측, 2024-2033년 시장

제8장 경쟁 상황

• 소개
• 주요 성공 전략
• 주요 10개 기업 제품 매핑
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝(2023년)

제9장 기업 개요

• Aratana Therapeutics, Inc.
• VetStem, Inc.
• Regeneus Ltd.
• Magellan Stem Cells
• PrimeGen Biotech, LLC
• Vetbiologics
• Boehringer Ingelheim
• Cell Therapy Sciences
• VETherapy Corporation
• MediVet Biologics LLC

ksm

영문 목차

영문목차

Animal Stem Cell Therapy Market

The animal stem cell therapy market was valued at $256.0 million in 2023 and is projected to reach $440.0 million by 2033, growing at a CAGR of 5.6% from 2024 to 2033.

Animal stem cell therapy is a procedure which involves the usage of stem cells to treat injuries or cure diseases in animals. Stem cells are the undifferentiated cells inside a living body which possess the capacity to give rise to new cells with different functionalities. This ability of stem cells makes them essential for the repair of damaged tissues and organs. To perform the therapy, the stem cells are harvested from diverse body parts, including bone marrow, umbilical cord blood, or fat tissue. The therapy has proven to be beneficial in the treatment of different conditions such as osteoarthritis, neurological disorders, tendon & ligament injuries, and various autoimmune diseases.

Increase in the ownership of pets globally, along with surge in expenditure on their lifestyle and health is a key driver of the animal stem cell therapy market. In addition, prevalence of chronic diseases and health-related disorders is rising among animals, thereby boosting the demand for stem cell therapy. With progressing technology, the trend of integrating AI in stem cell therapy is gaining prominence. AI is proving to be an unprecedented tool for achieving precision and addressing complications during the treatment. The tool helps to design a reliable framework for different procedures, including classification of stem cells colony, identification of cellular morphology, characterization of undescribed morphological traits in cancer stem cells, and prediction of drug effects.

However, the costs of animal stem cell therapies are significantly high, restricting the pet owners with limited budgets from affording such treatments. In addition, the market development is hampered by the ethical considerations surrounding the utility of stem cells, as compliance with such regulations is an intricate and lengthy procedure. For instance, the European Medicines Agency has implemented a rigorous evaluation process pertaining to stem cell therapies for veterinary use.

Segment Review

The animal stem cell therapy market is segmented into type, species, end user, and region. On the basis of type, the market is bifurcated into allogenic and autologous. As per species, it is divided into dog, cat, and horse. Depending on end user, it is classified into veterinary hospitals and research organizations. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type, the allogenic segment accounted for the highest market share in 2023.

As per species, the dog segment acquired high stakes in the market in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The leading players operating in the global animal stem cell therapy market include Aratana Therapeutics, Inc., VetStem, Inc., Regeneus Ltd., Magellan Stem Cells, PrimeGen Biotech, LLC, Vetbiologics, Boehringer Ingelheim, Cell Therapy Sciences, VETherapy Corporation, and MediVet Biologics LLC. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Additional company profiles with specific to client's interest

Key Market Segments

By Type

• Allogenic
• Autologous

By Species

• Dog
• Cat
• Horse

By End User

• Veterinary Hospitals
• Research Organizations

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA

Key Market Players:

• Aratana Therapeutics, Inc.
• VetStem, Inc.
• Regeneus Ltd.
• Magellan Stem Cells
• PrimeGen Biotech, LLC
• Vetbiologics
• Boehringer Ingelheim
• Cell Therapy Sciences
• VETherapy Corporation
• MediVet Biologics LLC

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report Description
• 1.2. Key Market Segments
• 1.3. Key Benefits
• 1.4. Research Methodology
  • 1.4.1. Primary Research
  • 1.4.2. Secondary Research
  • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

• 3.1. Market Definition and Scope
• 3.2. Key Findings
  • 3.2.1. Top Investment Pockets
  • 3.2.2. Top Winning Strategies
• 3.3. Porter's Five Forces Analysis
  • 3.3.1. Bargaining Power of Suppliers
  • 3.3.2. Threat of New Entrants
  • 3.3.3. Threat of Substitutes
  • 3.3.4. Competitive Rivalry
  • 3.3.5. Bargaining Power among Buyers
• 3.4. Market Dynamics
  • 3.4.1. Drivers
  • 3.4.2. Restraints
  • 3.4.3. Opportunities

CHAPTER 4: ANIMAL STEM CELL THERAPY BY TYPE, BY SPECIES (DOG, CAT, HORSE) BY END USER (VETERINARY HOSPITALS, RESEARCH ORGANIZATIONS) : OPPORTUNITY ANALYSIS AND INDUSTRY FORECAST, 2024-2033 MARKET, BY TYPE

• 4.1. Market Overview
  • 4.1.1 Market Size and Forecast, By Type
• 4.2. Allogenic
  • 4.2.1. Key Market Trends, Growth Factors and Opportunities
  • 4.2.2. Market Size and Forecast, By Region
  • 4.2.3. Market Share Analysis, By Country
• 4.3. Autologous
  • 4.3.1. Key Market Trends, Growth Factors and Opportunities
  • 4.3.2. Market Size and Forecast, By Region
  • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: ANIMAL STEM CELL THERAPY BY TYPE, BY SPECIES (DOG, CAT, HORSE) BY END USER (VETERINARY HOSPITALS, RESEARCH ORGANIZATIONS) : OPPORTUNITY ANALYSIS AND INDUSTRY FORECAST, 2024-2033 MARKET, BY SPECIES

• 5.1. Market Overview
  • 5.1.1 Market Size and Forecast, By Species
• 5.2. Dog
  • 5.2.1. Key Market Trends, Growth Factors and Opportunities
  • 5.2.2. Market Size and Forecast, By Region
  • 5.2.3. Market Share Analysis, By Country
• 5.3. Cat
  • 5.3.1. Key Market Trends, Growth Factors and Opportunities
  • 5.3.2. Market Size and Forecast, By Region
  • 5.3.3. Market Share Analysis, By Country
• 5.4. Horse
  • 5.4.1. Key Market Trends, Growth Factors and Opportunities
  • 5.4.2. Market Size and Forecast, By Region
  • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: ANIMAL STEM CELL THERAPY BY TYPE, BY SPECIES (DOG, CAT, HORSE) BY END USER (VETERINARY HOSPITALS, RESEARCH ORGANIZATIONS) : OPPORTUNITY ANALYSIS AND INDUSTRY FORECAST, 2024-2033 MARKET, BY END USER

• 6.1. Market Overview
  • 6.1.1 Market Size and Forecast, By End User
• 6.2. Veterinary Hospitals
  • 6.2.1. Key Market Trends, Growth Factors and Opportunities
  • 6.2.2. Market Size and Forecast, By Region
  • 6.2.3. Market Share Analysis, By Country
• 6.3. Research Organizations
  • 6.3.1. Key Market Trends, Growth Factors and Opportunities
  • 6.3.2. Market Size and Forecast, By Region
  • 6.3.3. Market Share Analysis, By Country

CHAPTER 7: ANIMAL STEM CELL THERAPY BY TYPE, BY SPECIES (DOG, CAT, HORSE) BY END USER (VETERINARY HOSPITALS, RESEARCH ORGANIZATIONS) : OPPORTUNITY ANALYSIS AND INDUSTRY FORECAST, 2024-2033 MARKET, BY REGION

• 7.1. Market Overview
  • 7.1.1 Market Size and Forecast, By Region
• 7.2. North America
  • 7.2.1. Key Market Trends and Opportunities
  • 7.2.2. Market Size and Forecast, By Type
  • 7.2.3. Market Size and Forecast, By Species
  • 7.2.4. Market Size and Forecast, By End User
  • 7.2.5. Market Size and Forecast, By Country
  • 7.2.6. U.S. Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
    • 7.2.6.1. Market Size and Forecast, By Type
    • 7.2.6.2. Market Size and Forecast, By Species
    • 7.2.6.3. Market Size and Forecast, By End User
  • 7.2.7. Canada Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
    • 7.2.7.1. Market Size and Forecast, By Type
    • 7.2.7.2. Market Size and Forecast, By Species
    • 7.2.7.3. Market Size and Forecast, By End User
  • 7.2.8. Mexico Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
    • 7.2.8.1. Market Size and Forecast, By Type
    • 7.2.8.2. Market Size and Forecast, By Species
    • 7.2.8.3. Market Size and Forecast, By End User
• 7.3. Europe
  • 7.3.1. Key Market Trends and Opportunities
  • 7.3.2. Market Size and Forecast, By Type
  • 7.3.3. Market Size and Forecast, By Species
  • 7.3.4. Market Size and Forecast, By End User
  • 7.3.5. Market Size and Forecast, By Country
  • 7.3.6. France Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
    • 7.3.6.1. Market Size and Forecast, By Type
    • 7.3.6.2. Market Size and Forecast, By Species
    • 7.3.6.3. Market Size and Forecast, By End User
  • 7.3.7. Germany Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
    • 7.3.7.1. Market Size and Forecast, By Type
    • 7.3.7.2. Market Size and Forecast, By Species
    • 7.3.7.3. Market Size and Forecast, By End User
  • 7.3.8. Italy Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
    • 7.3.8.1. Market Size and Forecast, By Type
    • 7.3.8.2. Market Size and Forecast, By Species
    • 7.3.8.3. Market Size and Forecast, By End User
  • 7.3.9. Spain Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
    • 7.3.9.1. Market Size and Forecast, By Type
    • 7.3.9.2. Market Size and Forecast, By Species
    • 7.3.9.3. Market Size and Forecast, By End User
  • 7.3.10. UK Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
    • 7.3.10.1. Market Size and Forecast, By Type
    • 7.3.10.2. Market Size and Forecast, By Species
    • 7.3.10.3. Market Size and Forecast, By End User
  • 7.3.11. Rest of Europe Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
    • 7.3.11.1. Market Size and Forecast, By Type
    • 7.3.11.2. Market Size and Forecast, By Species
    • 7.3.11.3. Market Size and Forecast, By End User
• 7.4. Asia-Pacific
  • 7.4.1. Key Market Trends and Opportunities
  • 7.4.2. Market Size and Forecast, By Type
  • 7.4.3. Market Size and Forecast, By Species
  • 7.4.4. Market Size and Forecast, By End User
  • 7.4.5. Market Size and Forecast, By Country
  • 7.4.6. China Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
    • 7.4.6.1. Market Size and Forecast, By Type
    • 7.4.6.2. Market Size and Forecast, By Species
    • 7.4.6.3. Market Size and Forecast, By End User
  • 7.4.7. Japan Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
    • 7.4.7.1. Market Size and Forecast, By Type
    • 7.4.7.2. Market Size and Forecast, By Species
    • 7.4.7.3. Market Size and Forecast, By End User
  • 7.4.8. India Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
    • 7.4.8.1. Market Size and Forecast, By Type
    • 7.4.8.2. Market Size and Forecast, By Species
    • 7.4.8.3. Market Size and Forecast, By End User
  • 7.4.9. South Korea Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
    • 7.4.9.1. Market Size and Forecast, By Type
    • 7.4.9.2. Market Size and Forecast, By Species
    • 7.4.9.3. Market Size and Forecast, By End User
  • 7.4.10. Australia Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
    • 7.4.10.1. Market Size and Forecast, By Type
    • 7.4.10.2. Market Size and Forecast, By Species
    • 7.4.10.3. Market Size and Forecast, By End User
  • 7.4.11. Rest of Asia-Pacific Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
    • 7.4.11.1. Market Size and Forecast, By Type
    • 7.4.11.2. Market Size and Forecast, By Species
    • 7.4.11.3. Market Size and Forecast, By End User
• 7.5. LAMEA
  • 7.5.1. Key Market Trends and Opportunities
  • 7.5.2. Market Size and Forecast, By Type
  • 7.5.3. Market Size and Forecast, By Species
  • 7.5.4. Market Size and Forecast, By End User
  • 7.5.5. Market Size and Forecast, By Country
  • 7.5.6. Brazil Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
    • 7.5.6.1. Market Size and Forecast, By Type
    • 7.5.6.2. Market Size and Forecast, By Species
    • 7.5.6.3. Market Size and Forecast, By End User
  • 7.5.7. South Africa Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
    • 7.5.7.1. Market Size and Forecast, By Type
    • 7.5.7.2. Market Size and Forecast, By Species
    • 7.5.7.3. Market Size and Forecast, By End User
  • 7.5.8. Saudi Arabia Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
    • 7.5.8.1. Market Size and Forecast, By Type
    • 7.5.8.2. Market Size and Forecast, By Species
    • 7.5.8.3. Market Size and Forecast, By End User
  • 7.5.9. Rest of LAMEA Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
    • 7.5.9.1. Market Size and Forecast, By Type
    • 7.5.9.2. Market Size and Forecast, By Species
    • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

• 8.1. Introduction
• 8.2. Top Winning Strategies
• 8.3. Product Mapping of Top 10 Player
• 8.4. Competitive Dashboard
• 8.5. Competitive Heatmap
• 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

• 9.1. Aratana Therapeutics, Inc.
  • 9.1.1. Company Overview
  • 9.1.2. Key Executives
  • 9.1.3. Company Snapshot
  • 9.1.4. Operating Business Segments
  • 9.1.5. Product Portfolio
  • 9.1.6. Business Performance
  • 9.1.7. Key Strategic Moves and Developments
• 9.2. VetStem, Inc.
  • 9.2.1. Company Overview
  • 9.2.2. Key Executives
  • 9.2.3. Company Snapshot
  • 9.2.4. Operating Business Segments
  • 9.2.5. Product Portfolio
  • 9.2.6. Business Performance
  • 9.2.7. Key Strategic Moves and Developments
• 9.3. Regeneus Ltd.
  • 9.3.1. Company Overview
  • 9.3.2. Key Executives
  • 9.3.3. Company Snapshot
  • 9.3.4. Operating Business Segments
  • 9.3.5. Product Portfolio
  • 9.3.6. Business Performance
  • 9.3.7. Key Strategic Moves and Developments
• 9.4. Magellan Stem Cells
  • 9.4.1. Company Overview
  • 9.4.2. Key Executives
  • 9.4.3. Company Snapshot
  • 9.4.4. Operating Business Segments
  • 9.4.5. Product Portfolio
  • 9.4.6. Business Performance
  • 9.4.7. Key Strategic Moves and Developments
• 9.5. PrimeGen Biotech, LLC
  • 9.5.1. Company Overview
  • 9.5.2. Key Executives
  • 9.5.3. Company Snapshot
  • 9.5.4. Operating Business Segments
  • 9.5.5. Product Portfolio
  • 9.5.6. Business Performance
  • 9.5.7. Key Strategic Moves and Developments
• 9.6. Vetbiologics
  • 9.6.1. Company Overview
  • 9.6.2. Key Executives
  • 9.6.3. Company Snapshot
  • 9.6.4. Operating Business Segments
  • 9.6.5. Product Portfolio
  • 9.6.6. Business Performance
  • 9.6.7. Key Strategic Moves and Developments
• 9.7. Boehringer Ingelheim
  • 9.7.1. Company Overview
  • 9.7.2. Key Executives
  • 9.7.3. Company Snapshot
  • 9.7.4. Operating Business Segments
  • 9.7.5. Product Portfolio
  • 9.7.6. Business Performance
  • 9.7.7. Key Strategic Moves and Developments
• 9.8. Cell Therapy Sciences
  • 9.8.1. Company Overview
  • 9.8.2. Key Executives
  • 9.8.3. Company Snapshot
  • 9.8.4. Operating Business Segments
  • 9.8.5. Product Portfolio
  • 9.8.6. Business Performance
  • 9.8.7. Key Strategic Moves and Developments
• 9.9. VETherapy Corporation
  • 9.9.1. Company Overview
  • 9.9.2. Key Executives
  • 9.9.3. Company Snapshot
  • 9.9.4. Operating Business Segments
  • 9.9.5. Product Portfolio
  • 9.9.6. Business Performance
  • 9.9.7. Key Strategic Moves and Developments
• 9.10. MediVet Biologics LLC
  • 9.10.1. Company Overview
  • 9.10.2. Key Executives
  • 9.10.3. Company Snapshot
  • 9.10.4. Operating Business Segments
  • 9.10.5. Product Portfolio
  • 9.10.6. Business Performance
  • 9.10.7. Key Strategic Moves and Developments

관련자료